---
title: "NP47825 Multiple Sclerosis Medicines"
ocid: "ocds-r6ebe6-0000784629"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000784629"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000784629.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000784629.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2025-05-02"
---

# NP47825 Multiple Sclerosis Medicines

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-r6ebe6-0000784629

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000784629)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000784629.json)

## Summary

The Common Services Agency, also known as NHS National Services Scotland (NSS), has completed a procurement process titled "NP47825 Multiple Sclerosis Medicines," aimed at supplying multiple sclerosis medicines across NHS Scotland. The process used an open procurement method categorized under goods and was conducted through an open procedure. Key locations involved are defined under the National Health Service (Scotland) Act 1978 and other related acts, covering regions such as Edinburgh. The procurement comprised two lots, which have been awarded, and contracts were signed in April 2025. This completed procurement process took place over several stages, including planned delays in the initial phases, with significant steps conducted in January 2025 and contracts signed by April 15, 2025.

This tender represents a substantial business opportunity for suppliers in the pharmaceutical industry, particularly those able to provide medications and fulfil NHS Scotland's requirements. Large-scale pharmaceutical manufacturers such as Sandoz Ltd, Merck Serono Limited, and others were successful participants, highlighting how businesses with capabilities in producing and distributing specific medical goods can grow through public sector frameworks. Companies need to demonstrate compliance with UK regulatory standards and have well-established supply chains to participate effectively. Businesses that are geared towards providing community benefits and supporting sustainability initiatives are likely to align well with NHS Scotland's procurement objectives.

## Notice

Supply of multiple sclerosis medicines to NHS Scotland.

### Lot Information

Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules

Supply of fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules to NHS Scotland. The Authority has award this Lot as a single supplier Framework Agreement per product line to three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Supply of glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY529465 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 2 May 2025 |
| Submission deadline | 7 Feb 2025 |
| Future notice date | Not specified |
| Award date | 9 Apr 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £51,517,832 |
| Lots value | £51,517,832 |
| Awards value | Not specified |
| Contracts value | £48,571,280 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 8 |
| Supplier names | BIOGEN IDEC; MERCK SERONO; ORIFARM; RANBAXY (UK; SANDOZ; STADA UK - THORNTON & ROSS; TEVA; VIATRIS UK HEALTHCARE |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 2 May 2025 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY529465
- 8 Jan 2025 at 00:00 - TenderUpdate - OJEU - F14 - Corrigendum - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN521282
- 7 Jan 2025 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN521257

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN521257
  NP47825 Multiple Sclerosis Medicines - Supply of multiple sclerosis medicines to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY529465
  NP47825 Multiple Sclerosis Medicines - Supply of multiple sclerosis medicines to NHS Scotland.

## Notice URLs

- http://
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000784629
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000784629. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000784629.json.
